Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 1
2000 2
2001 1
2002 6
2003 1
2004 2
2005 2
2006 1
2007 3
2008 1
2009 3
2010 3
2011 3
2012 1
2013 1
2014 1
2015 2
2016 2
2017 8
2018 5
2019 3
2020 7
2021 1
2022 2
2023 2
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.
Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K, Ellenson LH, Caputo T, Lee AH, Conejo-Garcia JR, Glimcher LH. Cubillos-Ruiz JR, et al. Among authors: silberman pc. Cell. 2015 Jun 18;161(7):1527-38. doi: 10.1016/j.cell.2015.05.025. Epub 2015 Jun 11. Cell. 2015. PMID: 26073941 Free PMC article.
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery.
Gardner TJ, Bourne CM, Dacek MM, Kurtz K, Malviya M, Peraro L, Silberman PC, Vogt KC, Unti MJ, Brentjens R, Scheinberg D. Gardner TJ, et al. Among authors: silberman pc. Cancers (Basel). 2020 Aug 5;12(8):2175. doi: 10.3390/cancers12082175. Cancers (Basel). 2020. PMID: 32764348 Free PMC article. Review.
Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis.
Driscoll CB, Rich JM, Isaacson D, Nicolas J, Jiang Y, Mi X, Yang C, Kocsuta V, Goh R, Patel N, Li E, Siddiqui MR, Meyers T, Witte JS, Kachuri L, Zhang H, Beestrum M, Silberman P, Schaeffer EM, Kundu SD. Driscoll CB, et al. Among authors: silberman p. Cancers (Basel). 2025 Jan 24;17(3):390. doi: 10.3390/cancers17030390. Cancers (Basel). 2025. PMID: 39941759 Free PMC article. Review.
Bridging clinical informatics and implementation science to improve cancer symptom management in ambulatory oncology practices: experiences from the IMPACT consortium.
McCleary NJ, Merle JL, Richardson JE, Bass M, Garcia SF, Cheville AL, Mitchell SA, Jensen R, Minteer S, Austin JD, Tesch N, DiMartino L, Hassett MJ, Osarogiagbon RU, Wong S, Schrag D, Cella D, Smith AW, Smith JD; IMPACT Consortium. McCleary NJ, et al. JAMIA Open. 2024 Sep 4;7(3):ooae081. doi: 10.1093/jamiaopen/ooae081. eCollection 2024 Oct. JAMIA Open. 2024. PMID: 39234146 Free PMC article.
North Carolina's uninsured.
Silberman P, Odom CH, Lambeth T, Holmes GM, Dubay KL; Task Force on Covering the Uninsured. Silberman P, et al. N C Med J. 2006 May-Jun;67(3):183-91. N C Med J. 2006. PMID: 16846157 Review. No abstract available.
Managed care regulations: impact on quality?
Silberman P, James K. Silberman P, et al. Qual Manag Health Care. 2000 Winter;8(2):21-39. doi: 10.1097/00019514-200008020-00004. Qual Manag Health Care. 2000. PMID: 10787505 Review.
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Smith AW, DiMartino L, Garcia SF, Mitchell SA, Ruddy KJ, Smith JD, Wong SL, Cahue S, Cella D, Jensen RE, Hassett MJ, Hodgdon C, Kroner B, Osarogiagbon RU, Popovic J, Richardson K, Schrag D, Cheville AL; IMPACT Consortium. Smith AW, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad073. doi: 10.1093/jncics/pkad073. JNCI Cancer Spectr. 2023. PMID: 37930033 Free PMC article.
75 results